Protheragen-ING

Protheragen-ING logo

Protheragen-ING is engaged in the introduction of various chemical products to the global market, including active pharmaceutical ingredients (APIs), pharmaceutical excipients, veterinary chemicals, membrane materials, packaging materials. We are also a solution provider for chemistry-related analysis services.

Company Website

Product Listing

4-(4-Aminophenoxy)-N-methylpicolinamide inquiry  | Purity Not Available

Protheragen-ING

[4-(4-Aminophenoxy)(2-pyridyl)]-N-methylcarboxamide is an intermediate of Sorafenib, which is a kinase inhibitor drug used for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.

More Information Supplier Page

4-(4-Chloro-2-thienyl)-2-thiazolamine inquiry  | Purity Not Available

Protheragen-ING

4-(4-Chloro-2-thienyl)-2-thiazolamine can be used as organic synthesis intermediates and pharmaceutical intermediates, mainly used in laboratory research and development processes and chemical production processes.

More Information Supplier Page

4-(Aminomethyl)tetrahydro-2H-pyran inquiry  | 0.97%

Protheragen-ING

4-Aminomethyltetrahydropyran is a reagent that is used in core modification in discovery of CC214-2 which is an orally available , selective inhibitor of mTOR kinase. 4-Aminomethyltetrahydropyran is also used as a reagent in the development of pyrazoloquinolines as PDE10A inhibitor for the treatment of schizophrenia.

More Information Supplier Page

4-Amino-5-Methylpyridin-2-ol inquiry  | Purity Not Available

Protheragen-ING

4-Amino-5-methylpyridin-2(1H)-one has been used as a reactant for the synthesis of BAY 94-8862, a nonsteroidal antagonist of the mineralocorticoid receptor to be used for the treatment of cardiorenal diseases.

More Information Supplier Page